Yuxia Ouyang

Yuxia Ouyang

Auto-generated profile, based on publicly available information

Yuxia Ouyang

Department of Anesthesiology, Perioperative and Pain Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 January 2024 in Diabetes/Metabolism Research and Reviews
Verified
Journal Article
Closed access
NRNadia Ramsingh
Nadia Ramsingh
ALAuthors: Hung-Mo Lin
Authors: Hung-Mo Lin
YOYuxia Ouyang
Yuxia Ouyang
RRRamit Ravona-Springer
Ramit Ravona-Springer
ALAbigail Livny
Abigail Livny
MBMichal Schnaider Beeri
Michal Schnaider Beeri

7 May 2025 in Journal of Parkinson’s Disease
Verified
Journal Article
Open access
Zhi ChaiZhi Chai
Zhi Chai
YOYuxia Ouyang
Yuxia Ouyang
ADAnketse Debebe
Anketse Debebe
MPMellissa Picker
Mellissa Picker
WLWon-Jun Lee
Won-Jun Lee
IPInga Peter
Inga Peter
Background: Parkinson's disease (PD) is often accompanied by gastrointestinal symptoms. While elevated inflammatory biomarkers have been reported in PD patients compared to controls, the role of intestinal dysmotility and inflammation in disease manifestation is not fully understood. Objective: This study sought to determine if fecal biomarkers and genetic predisposition to intestinal inflammation could help identify PD subtypes for future targeted therapies. Methods: The association of disease activity, assessed through United Parkinson's disease Rating Scale (UPDRS) and Non-Motor Symptoms Questionnaire (NMSQ), with constipation severity, fecal calprotectin and six short-chain fatty acid (SCFA) levels, polygenic risk scores (PRS) for inflammatory bowel disease (IBD) and PD, and microbiota diversity were investigated in 95 participants with established PD using regression analyses. Unsupervised k-means clustering was applied to stratify PD patients based on inflammatory biomarkers. Results: Having constipation was linked to worse mentation (UPDRSI, adj. p = 0.03) and more limited daily living activities (UPDRSII, adj. p = 0.03), with symptom severity linearly associated with higher disease activity (UPDRSI, adj. p = 0.002; NMSQ-total, adj. p = 0.02). Fecal calprotectin was elevated in those with constipation ( p = 0.02) and associated with longer disease duration irrespective of the age (adj. p = 0.02). Cluster analysis demonstrated that PD patients with a higher non-motor symptom UPDRSII score were more likely to have more severe constipation, lower fecal SCFA levels, lower bacterial diversity, and higher PRS-CD and PRS-IBD. Conclusions: Gut dysmotility, along with pro-inflammatory intestinal profiles, and greater genetic predisposition to IBD were observed in PD patients with worse non-motor symptoms. Monitoring intestinal biomarkers may help identify PD patients for targeted interventions.

6 March 2025 in BJA Open
Verified
Journal Article
Open access
BSBlaine Stannard
Blaine Stannard
RERichard H. Epstein
Richard H. Epstein
EGEilon Gabel
Eilon Gabel
GNGirish N. Nadkarni
Girish N. Nadkarni
YOYuxia Ouyang
Yuxia Ouyang
IHIra S. Hofer
Ira S. Hofer
The risk of developing a persistent reduction in renal function after postoperative acute kidney injury (pAKI) is not well established. The goal of this investigation was to evaluate whether patients who develop pAKI have a greater decline in long-term renal function than patients who do not. In this multicentre retrospective propensity-matched study, anaesthesia data warehouses at three tertiary care hospitals were queried. Adult patients undergoing surgery with available preoperative and postoperative creatinine results and without baseline haemodialysis requirements were included. Patients were stratified by occurrence of pAKI as defined by the Acute Kidney Injury Network classification. The primary outcome was a decline in follow-up glomerular filtration rate (GFR) of 40% relative to baseline, based on follow-up outpatient visits from 0 to 36 months after hospital discharge. A propensity score-matched sample was used in Kaplan-Meier analysis and a piecewise Cox model to compare the time to reach a 40% decline in GFR for patients with and without pAKI. In 95 213 patients, the rate of pAKI ranged from 9.9% to 13.7%. In the piecewise Cox model, pAKI was associated with a significantly increased hazard of a 40% decline in GFR. The common-effect hazard ratio was 13.35 (95% confidence interval [CI] 10.79-16.51, P<0.001) for 0-6 months, 7.07 (5.52-9.05, P<0.001) for 6-12 months, 6.02 (4.69-7.74, P<0.001) for 12-24 months, and 4.32 (2.65-7.05, P<0.001) for 24-36 months. pAKI is associated with a significantly increased hazard of a 40% decline in GFR up to 36 months after surgery across three institutions.

24 January 2025 in International Psychogeriatrics
Verified
Journal Article
Open access
YOYuxia Ouyang
Yuxia Ouyang
DMDavid Manier
David Manier
RRRamit Ravona-Springer
Ramit Ravona-Springer
MMMery Mamistalov
Mery Mamistalov
DGDar Gelblum
Dar Gelblum
EGElizabeth Guerrero-Berroa
Elizabeth Guerrero-Berroa
Depression is a chronic disorder that significantly affects functional decline in older adults, especially those with type 2 diabetes (T2D). Ethnic groups may experience different depression risks and severities, yet the effect of ethnicity on depression trajectories and specific dimensions in older adults with T2D remains largely unexamined. We examined the longitudinal associations of ethnicity with depression and its specific dimensions over time in older Ashkenazi and non-Ashkenazi Jews with T2D. Generalized estimating equations (GEE) models were employed to analyze the longitudinal associations of ethnicity with numbers of depressive symptoms and specific depression dimension, adjusting for sociodemographics, cognition, T2D characteristics, and cardiovascular risk factors. Community-dwelling older adults from the longitudinal Israel Diabetes and Cognitive Decline (IDCD) study. 902 Ashkenazi and non-Ashkenazi Jews, mean age= 72.3 years. The Geriatric Depression Scale-15 (GDS-15) and its five dimensions: Dysphoric Mood, Withdrawal Apathy-Lack of Vigor, Anxiety, Hopelessness, and Memory Complaint. At baseline, Ashkenazi Jews reported significantly lower GDS-15 scores compared to non-Ashkenazi Jews. They exhibited lower scores in Dysphoric Mood and Hopelessness dimensions. GEE models confirmed these findings, showing Ashkenazi Jews had significantly lower total GDS-15 scores (β = 0.86, 95 % CI 0.75-0.99; p = 0.03), Dysphoric Mood (β = 0.76 (0.52-0.90], p = 0.006), Hopelessness (β = 0.74 [0.58-0.95], p = 0.017) and lower rates of clinical depression (OR= 0.68 [0.52-0.90], p = 0.006). These data offered no evidence of a difference in trends between the Ashkenazi and non-Ashkenazi groups on depression trajectories. Ethnicity is associated with the longitudinal trajectories of depression and its specific dimensions in older adults with T2D. Further investigation of contributing factors, including social determinants of health, is essential.

9 October 2026 in Anesthesia & Analgesia
Verified
Journal Article
Closed access
DSDanielle Scharp
Danielle Scharp
KMKerry Meyers
Kerry Meyers
Girish N. NadkarniGirish N. Nadkarni
Girish N. Nadkarni
AFAlex Federman
Alex Federman
CSCatherine Sarkisian
Catherine Sarkisian
IHIra Hofer
Ira Hofer
BACKGROUND: Postoperative delirium affects up to 50% of older adults with cognitive impairment, yet preoperative identification of at-risk patients remains limited. Artificial intelligence methods, such as natural language processing, can extract cognitive impairment signals from electronic health records and enable targeted clinical decision support interventions to promote adherence to perioperative best practices and reduce postoperative delirium. We aimed to evaluate the effectiveness of an artificial intelligence-driven non-interruptive clinical decision support intervention in reducing postoperative delirium by promoting adherence to best practices among anesthesia teams caring for surgical patients with cognitive impairment. METHODS: We conducted a pragmatic randomized controlled trial embedded within routine clinical care at The Mount Sinai Hospital in New York City from June 20, 2023, to August 31, 2024, including patients with preoperative cognitive impairment identified immediately before surgery using a validated natural language processing algorithm, Mini-Mental State Examination scores, or diagnostic codes. Patients were randomized to an artificial intelligence-driven non-interruptive clinical decision support intervention within the electronic health record to promote adherence to best practices among anesthesia teams or routine perioperative care. The primary outcome was postoperative delirium, assessed with the 4 A’s Test within seven days postoperatively. Secondary outcomes were adherence to 12 perioperative best practices. We used chi-square tests for primary and secondary outcome analyses. RESULTS: Overall, 7294 patients were identified as having cognitive impairment immediately before surgery and were randomized to the intervention (n = 3624) or control (n = 3670) group. In total, 1255/7294 (17.2%) patients had documented postoperative delirium assessments, of whom 426/1255 (34%) developed this condition. Between intervention and control groups, there were no statistically significant differences in POD incidence (225/641, 35.1% vs 201/614, 32.7%, P = .37) or best practice adherence (all P > .05). CONCLUSIONS: In this pragmatic randomized controlled trial, less than 20% of the sample had documented delirium assessments due to variability in routine POD screening practices, limiting our ability to conclude that artificial intelligence-driven clinical decision support was not effective in preventing postoperative delirium. However, based on our secondary outcome analyses, the intervention did not significantly change best practice adherence. Further work is needed to determine the best way to use these tools effectively.

10 June 2022 in The Joint Commission Journal on Quality and Patient Safety
Verified
Journal Article
Closed access
CFChristopher E. Ferrer
Christopher E. Ferrer
DMDebbie C. Mokuolu
Debbie C. Mokuolu
ALAuthors: Hung-Mo Lin
Authors: Hung-Mo Lin
YOYuxia Ouyang
Yuxia Ouyang
TSThomas Schiano
Thomas Schiano
NSNatalie K. Smith
Natalie K. Smith